The role of vitreoretinal surgery in the treatment of posttraumatic macular hole

Retina

Volumn 17, Issue 5, 1997, Pages 372-377

  García Arumí, José ^a,b   Corcostegui, Borja ^a   Cavero, Luis ^a   Sararols, Laura ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLUNT TRAUMA; CLINICAL ARTICLE; CLINICAL FEATURE; EYE INJURY; FEMALE; FOLLOW UP; HUMAN; MALE; RETINA HEMORRHAGE; RETINA MACULA HOLE; RETINA SURGERY; SCHOOL CHILD; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 0344333480     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-199709000-00003     Document Type: Article

References (19)

1. Aaberg TM. Macular holes: a review. Surv Ophthalmol 1970;15:139-162.
2. Aaberg TM, Blair CJ, Gass JDM. Macular holes. Am J Ophthalmol 1970;69:555-562.
3. Gass JDM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. St Louis: CV Mosby, 1987;2:684-693.
4. Benson WE, Shakin J, Sarin LK. Blunt trauma. In: Tasman W, Jaeger EA, eds. Duane's Clinical Ophthalmology, vol. 3, ch. 31. Philadelphia: JB Lippincott, 1988:4.
5. Bressler SB, Bressler NM. Traumatic maculopathies. In: Shingleton BJ, Hersh PS, Kenyon KR, eds. Eye Trauma. St. Louis: CV Mosby Year Book, 1991:19.
6. Rubin JS, Glaser BM, Thompson JT, Sjaarda RN, Pappas SS, Murphy RP. Vitrectomy, fluid - gas exchange and transforming growth factor beta-2 for the treatment of traumatic macular holes. Ophthalmology 1995;102:1840-1845.
7. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes: results for a pilot study. Arch Ophthalmol 1991;109:654-659.
8. Patel AC, Wendel RT. Vitrectomy for macular hole. Semin Ophthalmol 1994;9:47-55.
9. Glaser BM, Michels RG, Kuppermann BD, et al. Transforming growth factor β2 for the treatment of full-thickness macular holes: a prospective randomized study. Ophthalmology 1992;99:1162-1173.
10. Wendel RT, Patel AC, Kelly NE, et al. Vitreous surgery for macular holes. Ophthalmology 1993;100:1671-1676.
11. Smiddy WE, Glaser BM, Thompson JT, et al. Transforming growth factor β2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding macular holes: preliminary anatomic results of a multicenter prospective randomized study. Retina 1993;13:296-301.
12. Garcia-Arumi J, Corcostegui B, Mateo C, et al. Surgical management of idiopathic senile macular hole. First international Symposium of Ophthalmology, Bordeaux, 1993:298.
13. Garcia-Arumi J, Salvador F, Mateo C, Corcostegui B. Tratamiento quirúrgico del agujero macular idiopático. Annals D'Oftalmología 1994;4:23-29.
14. Liggett PE, Skolik SA, Horio B, Saito Y, Alfaro V, Mieler W. Human autologous serum for the treatment of full-thickness macular holes. Ophthalmology 1995;102:1071-1076.
15. Gaudric A, Massin P, Paques M, et al. Autologous platelet concentrate for the treatment of full-thickness macular hole. Graefes Arch Clin Exp Ophthalmol 1995;233:549-554.
16. Freeman W, Stanley P, Jungw Q, Wael E, Mishell III D, Bailey I. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Arch Ophthalmol 1997;115:11-21.
17. Gass JDM. Reappraisal of macular hole classification. Am J Ophthalmol 1995;119:752-759.
18. Thompson JT, Glaser BM, Sjaarda RN, Murphy RP. Progression of nuclear esclerosis and long-term visual results of vitrectomy with transforming growth factor-β2 for macular holes. Am J Ophthalmol 1995;119:49-54.
19. Cherfan JM, Michels RG, Bustros S, et al. Nuclear sclerotic cataract after vitrectomy for idiopathic epiretinal membranes causing macular pucker. Am J Ophthalmol 1991;111:433-438.